Breeders split: EPO plant edict clarifies, stifles, misses mark Seed makers including Corteva are glad to have legal certainty after the Pepper ruling, but Bayer says it stems R&D and others have wider complaints By Patrick Wingrove June 01 2020
The Top 250 Women in IP 2020 Managing IP reveals this year's leading female IP practitioners in private practice By Managing IP Correspondent May 29 2020
This week in IP – EU chief wants SEP ‘solutions’, Australian patent reform, all or noth... Managing IP rounds up the latest trademark, patent and copyright news, including some stories you may have missed By Patrick Wingrove May 29 2020
This week in IP – Plants non-patentable (again), SCOTUS swats preclusion rule, National... Managing IP rounds up the latest trademark, copyright and patent news, including some stories you might have missed By Patrick Wingrove May 15 2020
Experts warn AI inventorship debate will only heat up AI legal specialists debated how companies will manage if machines continue to be refused patent inventorship By Charlotte Kilpatrick May 14 2020
A stranger’s guide to pharma IP collaboration during COVID-19 In-house counsel from Eli Lilly, Novartis and other companies set out how to protect IP in collaborations with third parties and competitors By Charlotte Kilpatrick May 07 2020
Royalty Pharma ‘throws grenade’ into patent filing calculations Lawyers lay out how the CJEU decision has provided some clarity on SPC law but raised confusion around the terms ‘developed’ and ‘independent’ By Patrick Wingrove May 06 2020
IP STARS 2020: New rankings for firms and practitioners We published more than 60 IP ranking tables and the rankings of the leading IP practitioners in private practice By Kingsley Egbuonu May 03 2020
CJEU rejects inventive advance test in latest SPC ruling In today’s Royalty Pharma decision, the EU’s highest court affirmed the two-step test from Teva v Gilead and dismissed another test created by Judge Arnold By Patrick Wingrove April 30 2020
